Paulus Hangula, the Acting Director and senior economist from the Competition Commission of Namibia says they have noted the public’s concern that prices charged for the testing of Covid-19 at private facilities in the country are exorbitant and may not fairly reflect the reasonable costs incurred in the procurement and administration of the tests. He added that in the alternative, the uniformity of high pricing further raises suspicion of there being regulatory facilitation of collusion among competitors in the procurement, supply, and administration of Covid-19 testing.